FINWIRES · TerminalLIVE
FINWIRES

TripAdvisor's Use of Proceeds From TheFork Sale a Potential Catalyst, Wedbush Says

By

TripAdvisor's (TRIP) plan to use proceeds from the proposed sale of TheFork on share buybacks, debt paydown and Experiences investment may act as a catalyst for shares, Wedbush said in a note Thursday.

The brokerage said it expects Q2 revenue of $526 million, compared with consensus of $503 million, adjusted earnings before interest, taxes, depreciation, and amortization of $83.2 million, versus $82.1 million, and adjusted EPS of $0.42, compared with $0.37.

Wedbush said its estimates reflect its expectation for continued Experiences/Viator momentum, offset by anticipated low-double-digit percentage decline in Hotels & Other as volume headwinds persist.

Wedbush maintained an outperform rating with a $20 price target.

Price: $14.19, Change: $-0.39, Percent Change: -2.67%

Related Articles

Wire

Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Houlihan Lokey (HLI) reported fiscal Q1 adjusted earnings late Wednesday of $1.35 per diluted share, down from $2.14 a year earlier.Analysts polled by FactSet expected $1.64.Revenue in the three months ended June 30 fell to $511 million from $605 million a year earlier.Analysts expected $602.4 million.Houlihan Lokey shares fell 6.6% in after-hours trading.

$HLI
Wire

Four Corners Property Trust Q2 AFFO, Revenue Rise

Four Corners Property Trust (FCPT) reported Q2 adjusted funds from operations late Wednesday of $0.45 per diluted share, up from $0.44 a year earlier.Analysts polled by FactSet expected $0.45.Revenue in the quarter ended June 30 rose to $78.4 million from $72.8 million a year earlier.Four analysts expected $79 million.The company's shares rose 2% in after-hours trading.

$FCPT
Wire

Corcept Therapeutics Q2 Earnings, Revenue Rise; Shares Jump After Hours

Corcept Therapeutics (CORT) reported Q2 earnings late Wednesday of $0.36 per diluted share, up from $0.29 a year earlier.Analysts polled by FactSet expected $0.02.Revenue for the three months ended June 30 rose to $256.1 million from $194.4 million a year earlier.Analysts expected $221.1 million.The company boosted full-year revenue guidance to $1.1 billion to $1.2 billion from the prior forecast of $950 million to $1.05 billion.Analysts project $999.5 million.Corcept shares jumped 18% in after-hours trading.

$CORT